Brief: Zealand Pharma Initiates $200 Mln Share Buy-Back Program

Zealand Pharma A/S

07/05/2026 05:57

May 7 (Reuters) - Zealand Pharma A/S ZELA.CO:

REG-ZEALAND PHARMA INITIATES USD 200 MILLION / DKK 1.3 BILLION SHARE BUY-BACK PROGRAM

ROBUST CASH POSITION OF USD 2.3 BILLION (DKK 14.5 BILLION) AS OF MARCH 31, 2026

MILESTONE PAYMENTS OF USD 700 MILLION FROM ROCHE IN 2026

WILL BUY BACK OWN SHARES FOR A MAXIMUM TOTAL CONSIDERATION OF DKK 1.3 BILLION AND A MAXIMUM OF 7,152,557 SHARES

TO BUY BACK UP TO 7,152,557 SHARES FOR DKK 1.3 BILLION FROM MAY 7 TO OCT 31, 2026

Source text: ID:nGNE2F5Chw

Further company coverage: ZELA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))